Revvity, Inc. (FRA:PKN)

Intra-Cellular Therapies Revenue

Revvity had revenue of $720.28M USD in the quarter ending June 29, 2025, with 4.13% growth. This brings the company's revenue in the last twelve months to $2.80B, up 3.33% year-over-year. In the year 2024, Revvity had annual revenue of $2.76B with 0.16% growth.

• Revenue (ttm): $2.80B
• Revenue Growth: +3.33%
• P/S Ratio: 3.77
• Revenue / Employee: $254.41K
• Employees: 11,000
• Market Cap: 9.01B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 29, 2024	2.76B	4.46M	0.16%
Dec 31, 2023	2.75B	-561.25M	-16.95%
Jan 1, 2023	3.31B	-515.99M	-13.48%
Jan 2, 2022	3.83B	1.16B	43.73%
Jan 3, 2021	2.66B	-220.44M	-7.64%